Global Bio-chem Technology Group Company Limited
GBCMF
$0.005
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 75.98M | 76.22M | 70.91M | 70.68M | 57.47M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 75.98M | 76.22M | 70.91M | 70.68M | 57.47M |
| Cost of Revenue | 65.65M | 65.86M | 61.09M | 60.90M | 53.25M |
| Gross Profit | 10.33M | 10.36M | 9.82M | 9.79M | 4.22M |
| SG&A Expenses | 8.64M | 8.67M | 11.74M | 11.70M | 10.99M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 1.03M | 1.03M | -3.37M | -3.36M | 3.35M |
| Total Operating Expenses | 75.33M | 75.57M | 69.46M | 69.24M | 67.59M |
| Operating Income | 653.60K | 655.70K | 1.45M | 1.45M | -10.12M |
| Income Before Tax | -9.91M | -9.94M | 58.10M | 57.91M | -10.09M |
| Income Tax Expenses | -- | -- | -1.54M | -1.54M | -- |
| Earnings from Continuing Operations | -9.91M | -9.94M | 59.64M | 59.45M | -10.09M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.91M | -9.94M | 59.64M | 59.45M | -10.09M |
| EBIT | 653.60K | 655.70K | 1.45M | 1.45M | -10.12M |
| EBITDA | 3.66M | 3.67M | 6.95M | 6.93M | -1.98M |
| EPS Basic | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 8.91B | 8.91B | 8.95B | 8.95B | 8.91B |
| Average Diluted Shares Outstanding | 8.91B | 8.91B | 43.49B | 43.49B | 8.91B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |